Trane Technologies Stock Quote TT - Stock Price, News, Charts, Message Board, Trades

Professional-Grade Tools, for Individual Investors.

Premium

Current Price

346.13

Bid

Ask

Volume

0.00 Day's Range 0.00

184.02 52 Week Range 363.155

Market Cap

78.111B

Previous Close

346.13

Open

Last Trade

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

1,203,335

Shares Outstanding

225,670,231

Dividend Yield

0.97%

PE Ratio

38.60

Earnings Per Share (EPS)

8.97

Revenue

17.68B

Net Profit

2.02B

Trane Technologies manufactures and services commercial and residential HVAC systems and transportation refrigeration solutions under its prominent Trane, American Standard, and Thermo King brands. The $14 billion company generates approximately 70% of sales from equipment and 30% from parts and ser... Trane Technologies manufactures and services commercial and residential HVAC systems and transportation refrigeration solutions under its prominent Trane, American Standard, and Thermo King brands. The $14 billion company generates approximately 70% of sales from equipment and 30% from parts and services. While the firm is domiciled in Ireland, North America accounts for over 70% of its revenue. Show more

Sector

Automatic Regulatng Controls

Industry

General Industrial Mach & Eq

Website

www.ingersollrand.com

Headquarters

Dublin, Irl

Founded

2009

Trane Technologies plc is listed in the Automatic Regulatng Controls sector of the New York Stock Exchange with ticker TT. The last closing price for Trane Technologies was $346.13. Over the last year, Trane Technologies shares have traded in a share price range of $ 184.02 to $ 363.155.

Trane Technologies currently has 225,670,231 shares outstanding. The market capitalization of Trane Technologies is $78.11 billion. Trane Technologies has a price to earnings ratio (PE ratio) of 38.60.

Overall Flow

Bullish

Net Premium

459k

Calls / Puts

100.00%

Buys / Sells

100.00%

OTM / ITM

0.00%

Sweeps Ratio

0.00%

Acepodia Enters Strategic Clinical Collaboration with Pfizer to Accelerate Development of Antibody-Cell Conjugation-Based Cell Therapies in Autoimmune Diseases

Acepodia Enters Strategic Clinical Collaboration with Pfizer to Accelerate Development of Antibody-Cell Conjugation-Based Cell Therapies in Autoimmune Diseases PR Newswire ALAMEDA, Calif. and...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.75	-0.216213099631	346.88	350.62	339.13	1030393	344.45899617	CS
4	6.73	1.98291101945	339.4	363.155	339.13	969849	349.26647074	CS
12	4.92	1.44192725887	341.21	363.155	306.72	1203335	336.267499	CS
26	63.12	22.3030988304	283.01	363.155	279	1092845	324.40486055	CS
52	139.19	67.2610418479	206.94	363.155	184.02	1133372	276.55902214	CS
156	154.16	80.3042142001	191.97	363.155	120.64	1294697	200.05451961	CS
260	245.2	242.940651937	100.93	363.155	70	1307936	176.01422025	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
AACTAres Acquisition Corporation II	$ 10.79 (0.00%)	0
AAC.UAres Acquisition Corporation	$ 10.81 (0.00%)	0
AACAres Acquisition Corporation	$ 10.79 (0.00%)	0
AAAlcoa Corporation	$ 28.17 (0.00%)	0
AAgilent Technologies	$ 138.03 (0.00%)	0
AACTAres Acquisition Corporation II	$ 10.79 (0.00%)	0
AAC.UAres Acquisition Corporation	$ 10.81 (0.00%)	0
AACAres Acquisition Corporation	$ 10.79 (0.00%)	0
AAAlcoa Corporation	$ 28.17 (0.00%)	0
AAgilent Technologies	$ 138.03 (0.00%)	0
AACTAres Acquisition Corporation II	$ 10.79 (0.00%)	0
AAC.UAres Acquisition Corporation	$ 10.81 (0.00%)	0
AACAres Acquisition Corporation	$ 10.79 (0.00%)	0
AAAlcoa Corporation	$ 28.17 (0.00%)	0
AAgilent Technologies	$ 138.03 (0.00%)	0